US Stock MarketDetailed Quotes
ARQT Arcutis Biotherapeutics
- 11.710
- +0.200+1.74%
Close Nov 27 16:00 ET
- 11.710
- 0.0000.00%
Post 20:01 ET
1.37BMarket Cap-7011P/E (TTM)
11.880High11.380Low1.70MVolume11.600Open11.510Pre Close19.72MTurnover2.02%Turnover RatioLossP/E (Static)117.04MShares13.17052wk High8.75P/B983.93MFloat Cap1.89052wk Low--Dividend TTM84.03MShs Float40.880Historical High--Div YieldTTM4.34%Amplitude1.760Historical Low11.627Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Arcutis Biotherapeutics Stock Forum
Arcutis Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(9.38%),David Rosen(9.38%)
Long-term! 😜
1 MINUTE AGO, 8:20 AM EDT
VIA GLOBENEWSWIRE
New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types | ARQT Stock News
No comment yet